Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts1

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 7, 2014, Pages 598-604

  Shamhart, Patricia E ^a,b   Luther, Daniel J ^a,b   Adapala, Ravi K ^a,b   Bryant, Jennifer E ^c   Petersen, Kyle A ^a   Meszaros, J Gary ^a,b   Thodeti, Charles K ^a,b  

^a Northeastern Ohio Medical University   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c SHENANDOAH UNIVERSITY   (United States)

Author keywords

Cardiac fibroblast; Collagen; Diabetes; High glucose; Migration; Myofibroblast; Proliferation

Indexed keywords

COLLAGEN; GLUCOSE BLOOD LEVEL;

ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; FIBROBLAST; FIBROSIS; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HYPERGLYCEMIA; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; FIBROSIS; HYPERGLYCEMIA; MALE; MYOCARDIUM; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84903267895     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0490     Document Type: Article

References (34)

1. Aragno, M., Mastrocola, R., Alloatti, G., Vercellinatto, I., Bardini, P., Geuna, S., et al. 2008. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology, 149: 380-388. doi:10.1210/en.2007-0877. PMID:17901230.
2. Asbun, J., and Villarreal, F.J. 2006. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 47(4): 693-700. doi: 10.1016/j.jacc.2005.09.050. PMID:16487830.
3. Asbun, J., Manso, A.M., and Villarreal, F.J. 2005. Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E. Am. J. Physiol. Heart Circ. Physiol. 288: H227-H234. doi:10.1152/ ajpheart.00340.2004. PMID:15345478.
4. Deckert, T., Poulsen, J.E., and Larsen, M. 1978. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia, 14(6): 363-370. doi:10.1007/BF01228130 PMID:669100
5. Dorman, J.S., Laporte, R.E., Kuller, L.H., Cruickshanks, K.J., Orchard, T.J., Wagener, D.K., et al. 1984. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes, 33(3): 271-276. doi:10.2337/diab.33.3.271. PMID:6698317.
6. Kelly, D.J., Zhang, Y., Connelly, K., Cox, A.J., Martin, J., Krum, H., et al. 2007. Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 293: H2860-H2869. doi:10.1152/ajpheart.01167.2006. PMID:17720766.
7. Kim, Y.H., Heo, J.S., and Han, H.J. 2006. High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways. J. Cell. Physiol. 209(1): 94-102. doi:10.1002/jcp.20706. PMID:16775839.
8. Loganathan, R., Bilgen, M., Al-Hafez, B., and Smirnova, I.V. 2006. Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int. J. Cardiovasc. Imaging, 22: 81-90. doi:10.1007/s10554-005-5386-6. PMID:16362172.
9. Luther, D.J., Thodeti, C.K., Shamhart, P.E., Adapala, R.K., Hodnichak, C., Weihrauch, D., et al. 2012. Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction. Circ. Res. 110(6): 851-856. doi:10.1161/CIRCRESAHA.111.252734. PMID: 22343710.
10. Mak, K.H., Moliterno, D.J., Granger, C.B., Miller, D.P., White, H.D., Wilcox, R.G., et al. 1997. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J. Am. Coll. Cardiol. 30(1): 171-179.PMID:9207639.
11. Muona, P., Jaakkola, S., Zhang, R.-Z., Pan, T.-C., Pelliniemi, L., Risteli, L., et al. 1993. Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Am. J. Pathol. 142(5): 1586-1597. PMID:8494053.
12. Natarajan, R., Gonzales, N., Xu, L., and Nadler, J.L. 1992. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem. Biophys. Res. Commun. 187(1): 552-560. doi:10.1016/S0006-291X(05)81529-3. PMID:1520346.
13. Naugle, J.E., Olson, E.R., Zhang, X., Mase, S.E., Pilati, C.F., Maron, M.B., et al. 2006. Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am. J. Physiol. Heart Circ. Physiol. 290: H323-H330. doi:10.1152/ajpheart.00321.2005. PMID:16143656.
14. Neumann, S., Huse, K., Semrau, R., Diegeler, A., Gebhardt, R., Buniatian, G.H., et al. 2002. Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro. Hypertension, 39: 756-760. doi:10.1161/ hy0302.105295. PMID:11897758.
15. Olson, E.R., Naugle, J.E., Zhang, X., Bomser, J.A., and Meszaros, J.G. 2005. Inihibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am. J. Physiol. Heart Circ. Physiol. 288: H1131-1138. doi:10.1152/ ajpheart.00763.2004. PMID:15498824.
16. Olson, E.R., Shamhart, P.E., Naugle, J.E., and Meszaros, J.G. 2008. Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase C delta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension, 51: 704-711. doi:10.1161/HYPERTENSIONAHA. 107.098459. PMID:18195168.
17. Orchard, T.J., Costacou, T., Kretowski, A., and Nesto, R.W. 2006. Type 1 diabetes and coronary artery disease. Diabetes Care, 29(11): 2528-2538. doi:10.2337/ dc06-1161. PMID:17065698.
18. Peiro, C., Lafuente, N., Matesanz, N., Cercas, E., Llergo, J.L., Vallejo, S., et al. 2001. High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br. J. Pharmacol. 133(7): 967-974. doi:10.1038/sj.bjp.0704184. PMID:11487505.
19. Popov, D., and Simionescu, M. 2006. Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium. Arch. Physiol. Biochem. 12(4-5): 265-273. doi:10.1080/13813450601094573. PMID:17178601.
20. Porter, K.E., and Turner, N.A. 2009. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123(2): 255-278. doi:10.1016/j.pharmthera. 2009.05.002. PMID:19460403.
21. Swaney, J.S., Roth, D.M., Olson, E.R., Naugle, J.E., Meszaros, J.G., and Insel, P.A. 2005. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc. Natl. Acad. Sci. U.S.A. 102: 437-442. doi:10.1073/pnas.0408704102. PMID:15625103.
22. Shamhart, P.E., Luther, D.J., Hodson, B.R., Koshy, J.C., Ohanyan, V., and Meszaros, J.G. 2009. Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in the diabetic myocardium. Am. J. Physiol. Endocrinol. Metab. 297: E1147-E1153. doi:10.1152/ajpendo.00327.2009. PMID:19706787.
23. Sheu, M.L., Ho, F.M., Chao, K.F., Kuo, M.L., and Liu, S.H. 2004. Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-kappaB activation and cyclooxygenase-2 expression in mesangial cells. Mol. Pharmacol. 66(1): 187-196. doi:10.1124/mol.66.1.187. PMID:15213311.
24. Shimizu, M., Umeda, K., Sugihara, N., Yoshio, H., Ino, H., Takeda, R., et al. 1993. Collagen remodelling in myocardia of patients with diabetes. J. Clin. Pathol. 46: 32-36. doi:10.1136/jcp.46.1.32. PMID:7679418.
25. Tang, M., Zhang, W., Lin, H., Jiang, H., Dai, H., and Zhang, Y. 2007. High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2. Mol. Cell. Biochem. 301: 109-114. doi:10.1007/s11010-006-9401-6. PMID: 17206378.
26. Tsutsui, H., Matsushima, S., Kinugawa, S., Ide, T., Inoue, N., Ohta, Y., et al. 2007. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic hearts. Hypertens. Res. 30: 439-449. doi:10.1291/hypres.30.439. PMID:17587756.
27. Van Linthout, S., Riad, A., Dhayat, N., Westermann, D., Hilfiker-Kleiner, D., Noutsias, M., et al. 2007. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia, 50: 1977-1986. doi:10.1007/s00125-007-0719-8. PMID:17589825.
28. Varma, S., Lal, B., Zheng, R.K., Breslin, J.W., Saito, S., Pappas, P.J., et al. 2005. Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am. J. Physiol. Heart Circ. Physiol. 289: H1744-H1751. doi:10.1152/ajpheart.01088.2004. PMID:15964918.
29. Venkatachalam, K., Mummidi, S., Cortez, D.M., Prabhu, S.D., Valente, A.J., and handrasekar, B. 2008. Resveratrol inhibits high glucose-induced PI3K/Akt/ ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 294(5): H2078-H2087. doi:10.1152/ ajpheart.01363.2007. PMID:18310510.
30. Watson, P.A., Nesterova, A., Burant, C.F., Klemm, D.J., and Reusch, J.E. 2001. Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J. Biol. Chem. 276(49): 46142-46150. doi:10.1074/jbc.M104770200. PMID:11560925.
31. Yasunari, K., Kohno, M., Kano, H., Yokokawa, K., Horio, T., and Yoshikawa, J. 1995. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler. Thromb. Vasc. Biol. 15(12): 2207-2212. doi:10.1161/01.ATV.15.12. 2207. PMID:7489244.
32. Yuen, A., Laschinger, C., Talior, I., Lee, W., Chan, M., Birek, J., et al. 2010. Methylglyoxal- modified collagen promotes myofibroblast differentiation. Matrix Biol. 29: 537-548. doi:10.1016/j.matbio.2010.04.004. PMID:20423729.
33. Zhang, X., Stewart, J.A.J., Kane, I.D., Massey, E.P., Cashatt, D.O., and Carver, W.E. 2007. Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix. In Vitro Cell. Dev. Biol. Anim. 43: 297-305. doi:10.1007/s11626-007-9052-2. PMID:17849168.
34. Zheng, X.L., Yuan, S.G., and Peng, D.Q. 2007. Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment. Diabetologia, 50(4): 881-890. doi:10.1007/s00125-006-0543-6. PMID:17334654.